9 August 2018
Everyone is invited to attend the 2nd UK Fertility Preservation Conference on 14 September 2018 at St. Anne’s College at the University of Oxford. This meeting follows on from the 1st highly successful meeting in Edinburgh in 2017. Oxford is home to The Future Fertility Trust which is the main Fertility Preservation Centre in England. They provide a comprehensive tissue cryopreservation service for girls, boys and young adults alongside a dynamic research programme.
6 August 2018
Dr Lucy Mackillop, Dr Jane Hirst and their team from the Nuffield Department of Women's & Reproductive Health have won an award at the University’s first Vice-Chancellor’s Innovation Awards. Their GDm-healthTM: real-time management of gestational diabetes project was awarded ‘highly commended’ in the ‘Team Work’ category. The GDm-Health app allows pregnant women to track their blood glucose levels and stay in touch with their healthcare team.
23 July 2018
A global review involving almost 20 million people has shown that having diabetes significantly raises the risk of developing cancer, and for women the risk is even higher.
12 July 2018
Pregnant women are being invited by the University of Oxford and the NHS to take part in the world’s first clinical trial to prevent type 1 diabetes in babies and infants.Researchers want to find out if giving small amounts of oral insulin to babies on the National Institute for Health Research-supported trial can prevent type 1 diabetes, thus allowing mothers to protect their children from injecting insulin.
9 July 2018
Investigation of endometriosis-associated pain and interstitial cystitis/bladder pain syndrome by public-private partnership. Chronic pelvic pain is a condition with high unmet medical need and has a significant impact on quality of life, work efficiency & healthcare utilization. The disorder is frequently associated with endometriosis and bladder pain syndrome/interstitial cystitis – debilitating diseases affecting millions of women worldwide. An important new research programme focused on these diseases has recently been launched. It will be undertaken by a large international consortium including leading academic centres, small and medium-sized enterprises (SMEs), pain societies, patient organizations and pharmaceutical industry partners.
17 May 2018
Dr Jenny Tran (from The George Institute, Nuffield Department of Women's & Reproductive Health) is already a medical doctor, Rhodes scholar, and one of Forbes’ ‘30 under 30’, and she can now add Asian Women of Achievement award-winner to her list of accolades.
27 March 2018
Professor Terry Dwyer is stepping down from his role as Executive Director of The George Institute for Global Health at the University of Oxford to focus on his research into children’s cancer and childhood risk factors for heart disease and cancer in adults.
12 March 2018
Women with bigger waists relative to their hips face a proportionately greater risk of experiencing a heart attack than men who have a similar ‘apple shape’, new research from The George Institute for Global Health, (Nuffield Department of Women's & Reproductive Health).
12 March 2018
Professor Ahmed's lab is leading groundbreaking research to find ways of making paclitaxel chemotherapy more effective. Whilst many patients with ovarian cancer respond well to paclitaxel, about 60% do not. Overcoming such resistance to chemotherapy is a major challenge.
5 February 2018
Could you help us to continue to deliver ground-breaking research on healthy weight gain during pregnancy?
1 February 2018
Jo Poulton is a professor and honorary consultant in mitochondrial genetics at the Nuffield Department of Women's & Reproductive Health, where she works on diseases caused by mutant mitochondrial DNA. In an interview by the British Medical Journal, Prof Poulton discusses her biggest inspiration, her best career move, the living doctor she most admires and much more.
22 January 2018
Girls who start their periods before they turn 12 are at greater risk of developing heart disease and stroke in later life, according to a new study of nearly 300,000 women in the UK by The George Institute for Global Health at the University of Oxford.
22 January 2018
Cervical Cancer Prevention Week runs from 22nd - 28th January 2018. Every day, 9 women are diagnosed with Cervical Cancer and 2 women lose their lives. And yet 75% of cervical cancers can be prevented by cervical screening. The key messages of Prevention Week are for women to attend cervical screening when invited and to take up the HPV vaccination if aged 11-18.
27 November 2017
The number of people being diagnosed with heart failure in the UK continues to grow, and the poorest people are significantly more likely to be affected by the condition, new research from The George Institute for Global Health has found.
30 October 2017
For the first time, a strong link has been established between high blood pressure and the most common heart valve disorder in high-income countries, by new research from The George Institute for Global Health.
5 October 2017
A project set up to provide the first systematically collected population health data for women in Northern Cyprus has received a number of generous donations. This support will enable researchers to better understand health and illness patterns, as well as the personal, social and economic burden of disease, in this relatively isolated region.
26 September 2017
Celine Jones and Kevin Coward - key senior teaching staff for the Dept's MSc in Clinical Embryology, have been awarded a Bronze Employer Award for their excellent engagement with local school children interested in careers in STEM (science, technology, engineering and mathematics). The award was given by Science-Oxford and The Careers and Enterprise Company.
26 September 2017
Women with coronary heart disease are less likely to achieve treatment targets than men, finds a study published by the journal Heart. The authors, including Dr Sanne Peters, from The George Institute for Global Health UK, say a better understanding of sex disparities is needed to treat women with coronary heart disease more efficiently in all regions, especially in Asia and the Middle East.